O&G SAQs · Intrapartum care — obstetric emergencies
Amniotic fluid embolism — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on amniotic fluid embolism: the discriminating differential, the first-five-minute resuscitation with perimortem caesarean timing, product-targeted correction of the consumptive coagulopathy, and why the diagnosis remains clinical. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the discriminating feature, the drug with its dose, the target number, the time window. Write labelled points, not paragraphs, and answer the sub-part asked. [1]
Reveal model answer and mark schemeShowHide
(a) Differential diagnosis with the discriminating feature (4 marks)
One mark per diagnosis with its discriminator. A bare list without discriminators scores half. [1][2]
| Diagnosis | What distinguishes it from amniotic fluid embolism |
|---|---|
| Pulmonary thromboembolism | Hypoxia and right heart strain without early consumptive coagulopathy; risk factors usually present |
| Anaphylaxis | Identifiable trigger minutes before; urticaria, angioedema, bronchospasm; responds to adrenaline; no early DIC |
| High or total spinal block | Temporally locked to neuraxial dosing; ascending motor and sensory block with bradycardia; normal clotting |
| Local anaesthetic systemic toxicity | Follows a large local anaesthetic dose; perioral tingling and tinnitus precede seizure and arrhythmia; normal clotting |
| Eclampsia | Preceding hypertension and proteinuria; seizure with inter-ictal recovery; no profound hypoxia or DIC |
| Haemorrhage with dilutional coagulopathy | Coagulopathy proportionate to a large measured loss; amniotic fluid embolism produces coagulopathy out of proportion to loss |
Additional credit for naming peripartum cardiomyopathy, aortic dissection, myocardial infarction, sepsis, air embolism or drug error. [1]
(b) Immediate management, first five minutes (5 marks)
One mark per point with its reasoning, maximum five. [4][6]
- Declare a maternal collapse and activate the maternal cardiac arrest team, allocating airway, compressions, uterine displacement, drugs, scribe and neonatal roles. A protocolised, role-allocated first ten minutes is the intervention with the best evidence in this condition.[4]
- Airway and 100% oxygen, with early tracheal intubation by the most experienced operator. Hypoxia is what produces the neurological injury that determines outcome.[6][3]
- If pulseless: CPR flat on a firm surface, hands on the centre of the sternum, with continuous manual left uterine displacement. Drug doses and defibrillation energies are unchanged in pregnancy.[6]
- Set the clock and perform perimortem caesarean birth by 4 minutes in this undelivered woman at term. It is done in the room, for maternal benefit, because emptying the uterus relieves aortocaval compression.[6][1]
- Two large-bore cannulae above the diaphragm, bloods including fibrinogen, and activate the massive haemorrhage protocol pre-emptively. The coagulopathy is coming.[4][5]
- Vasopressors early and fluid cautiously — noradrenaline and vasopressin support the failing right ventricle; large-volume crystalloid distends it and worsens output.[3]
(c) Haematological management with targets (4 marks)
One mark each for the fibrinogen target and product, the platelet target, the ratio-based plasma and red cell strategy, and one for either tranexamic acid or the factor VIIa caveat. [5][1]
- Fibrinogen 0.7 g/L: give cryoprecipitate or fibrinogen concentrate immediately, targeting a fibrinogen at or above 2 g/L. Fibrinogen falls first and fastest in obstetric consumptive coagulopathy.[5]
- Platelets 62 × 10⁹/L: transfuse to keep platelets above 50 × 10⁹/L, with a higher trigger if she is going to theatre.[5][1]
- Red cells and fresh frozen plasma in a ratio-based massive transfusion pack until laboratory or viscoelastic guidance is available; use ROTEM or TEG to detect hypofibrinogenaemia and hyperfibrinolysis.[5][3]
- Tranexamic acid 1 g intravenously over 10 minutes for the haemorrhage component; calcium replacement for the citrate load; active warming throughout.[1][5]
- Recombinant activated factor VII only as a last resort after full conventional replacement — the systematic review of published cases found worse outcomes in treated women.[7]
(d) How the diagnosis is confirmed (2 marks)
One mark for stating that it is a clinical diagnosis of exclusion, one for naming the criteria or explaining why no test confirms it. [2]
- It is not confirmed by any test. Amniotic fluid embolism is a clinical diagnosis of exclusion made at the bedside. Fetal squames in maternal pulmonary blood are neither sensitive nor specific; tryptase, complement and zinc coproporphyrin are research tools.[1][2]
- The Clark/SMFM 2016 research criteria define cases for research, not for the bedside: sudden cardiorespiratory arrest, or hypotension with systolic pressure under 90 mmHg plus respiratory compromise; overt disseminated intravascular coagulation documented after the collapse; onset during labour or within 30 minutes of delivery of the placenta; and no fever of 38.0 degrees Celsius or above during labour. All four are required, deliberately trading sensitivity for specificity.[2]
References7ShowHide
- [1]Pacheco LD, Saade G, Hankins GD, Clark SL Amniotic fluid embolism: diagnosis and management Am J Obstet Gynecol, 2016.PMID 26987420
- [2]Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies Am J Obstet Gynecol, 2016.PMID 27372270
- [3]Pacheco LD, Clark SL, Klassen M, Hankins GDV Amniotic fluid embolism: principles of early clinical management Am J Obstet Gynecol, 2020.PMID 31376394
- [4]Combs CA, Montgomery DM, Toner LE, Dildy GA Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism Am J Obstet Gynecol, 2021.PMID 33417901
- [5]Erez O, Mastrolia SA, Thachil J Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management Am J Obstet Gynecol, 2015.PMID 25840271
- [6]Jeejeebhoy FM, Zelop CM, Lipman S, et al. Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association Circulation, 2015.PMID 26443610
- [7]Leighton BL, Wall MH, Lockhart EM, Phillips LE, Zatta AJ Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports Anesthesiology, 2011.PMID 21720243